![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
LUNAR™-HBV, a UNA Oligomer Combination for
the Treatment of Chronic Hepatitis B Virus Infection
|
|
|
Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
Christine Esau1, Pattraranee Limphong1, Kiyoshi Tachikawa1, James McSwiggen2, Wendy Taylor1, Michael Figa1, Priya Karmali1, David B. Smith3, Tse-I Lin3, Leonid Beigelman3, Pad Chivukula1
1Arcturus Therapeutics, San Diego, CA, USA; 2McSwiggen and Associates Biotech Consulting, Boston, MA, USA; 3Alios BioPharma Inc., a part of the Janssen Pharmaceutical Companies, South San Francisco, CA, USA
![HBV1](../images/112216/112216-12/HBV1.gif)
![HBV2](../images/112216/112216-12/HBV2.gif)
![HBV3](../images/112216/112216-12/HBV3.gif)
![HBV4](../images/112216/112216-12/HBV4.gif)
![HBV5](../images/112216/112216-12/HBV5.gif)
![HBV6](../images/112216/112216-12/HBV6.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|